Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Glenn Jr Md Phd Steele

Director at Ptc Therapeutics, Inc. (PTCT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.7M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 2SEC PTCTPtc Therapeutics, Inc. Sell Plan 12,00022,500 held (−35%) $65.16 $782K -9.1%
Jan 6SEC PTCTPtc Therapeutics, Inc. Sell Plan 12,00018,500 held (−39%) $76.35 $916K -22.4%
  • Sell

    Director Glenn Jr Md Phd Steele sold $782K of PTCT at $65.16 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Glenn Jr Md Phd Steele sold $916K of PTCT at $76.35 — cuts the stake by 39%; pre-scheduled 10b5-1 plan sale.